arrow
Back
M

Marta Canelo‐Vilaseca

Hop St Louis

1H-index
13Paper Count
24Citation Count
Published Papers 3
Publication Date
Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
err2026-03-02
err0
errOAAI
errMarta Canelo-Vilaseca; Mohamad Sabbah; Caterina Cristinelli; Côme Bommier; Pierre Sesques; Mikael Roussel; Pierre Bories; Vincent Allain; Amani Ouedrani; Ilenia De Bernardis; Agathe Vely; Pierre Stephan; Laetitia Vercellino; Fabienne Venet; Rémi Pescarmona; Roch Houot; François Vergez; Romain de Jorna; Isabelle Madelaine; Nathalie Parquet; Anne C. Brignier; Jérôme Larghero; Miryam Mebarki; Roberta Di Blasi; Sophie Caillat-Zucman; Catherine Thieblemont
errShare
errSave
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
err2026-01-08
err0
errOAAI
errMarta Canelo-Vilaseca; Mohamad Sabbah; Caterina Cristinelli; Bommier Côme; Pierre Sesques; Mikael Roussel; Pierre Bories; Vincent Allain; Amani Ouedrani; Ilenia De Bernardis; Agathe Vely; Pierre Stephan; Laetitia Vercellino; Fabienne Venet; Rémi Pescarmona; Roch Houot; François Vergez; Romain de Jorna; Isabelle Madelaine; Nathalie Parquet; Anne C. Brignier; Jérôme Larghero; Miryam Mebarki; Di Blasi Roberta; Sophie Caillat-Zucman; Catherine Thieblemont
errShare
errSave
Lymphodepletion chemotherapy in chimeric antigen receptor-engineered T (CAR-T) cell therapy in lymphoma
err2025-03-27
err0
errOAAI
errCanelo-Vilaseca, Marta; Sabbah, Mohamad; Di Blasi, Roberta; Cristinelli, Caterina; Sureda, Anna; Caillat-Zucman, Sophie; Thieblemont, Catherine
errShare
errSave